{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:44:31Z","timestamp":1768509871761,"version":"3.49.0"},"posted":{"date-parts":[[2024,4,22]]},"group-title":"Neuroscience","reference-count":53,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>INTRODUCTION<\/jats:title>\n                  <jats:p>Proteome changes associated with APOE4 variant carriage that are independent of Alzheimer\u2019s disease (AD) pathology and diagnosis are unknown. This study investigated APOE4 proteome changes in people with AD, mild cognitive impairment, and no impairment.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Clinical, APOE genotype, and cerebrospinal fluid (CSF) proteome and AD biomarker data was sourced from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) database. Proteome profiling was done using supervised machine learning.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We found an APOE4-specific proteome signature that was independent of cognitive diagnosis and AD pathological biomarkers, and increased risk of progression to cognitive impairment. Proteins were enriched in brain regions including the caudate and cortex and cells including endothelial cells, oligodendrocytes, and astrocytes. Enriched peripheral immune cells included T cells, macrophages, and B cells.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>DISCUSSION<\/jats:title>\n                  <jats:p>APOE4 carriers have a unique CSF proteome signature associated with a strong brain and peripheral immune and inflammatory phenotype that likely underlies APOE4 carriers\u2019 vulnerability to cognitive decline and AD.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.04.18.590160","type":"posted-content","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T19:10:11Z","timestamp":1713813011000},"source":"Crossref","is-referenced-by-count":0,"title":["Proteome profiling of cerebrospinal fluid using machine learning shows a unique protein signature associated with APOE4 genotype"],"prefix":"10.64898","author":[{"given":"Artur","family":"Shvetcov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Na","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather M.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne H.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin A.","family":"Finney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024062101200632000_2024.04.18.590160v2.1","doi-asserted-by":"crossref","unstructured":"Safieh M , Korczyn AD , Michaelson DM. ApoE4: An emerging therapeutic target for Alzhiemer\u2019s disease. BMC Medicine. 2019;17","DOI":"10.1186\/s12916-019-1299-4"},{"key":"2024062101200632000_2024.04.18.590160v2.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8346443"},{"key":"2024062101200632000_2024.04.18.590160v2.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2006.06.008"},{"key":"2024062101200632000_2024.04.18.590160v2.4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.201279298"},{"key":"2024062101200632000_2024.04.18.590160v2.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.04831.x"},{"key":"2024062101200632000_2024.04.18.590160v2.6","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R067249"},{"key":"2024062101200632000_2024.04.18.590160v2.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1662-x"},{"issue":"5-6","key":"2024062101200632000_2024.04.18.590160v2.8","first-page":"328","article-title":"APOE \u03b54 genotype and cognitive reserve effects on the cognitive functioning of healthy elders","volume":"44","year":"2018","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"2024062101200632000_2024.04.18.590160v2.9","doi-asserted-by":"crossref","unstructured":"O\u2019Dwyer L , Lamberton F , Matura S , et al. Reduced hippocampal volume in healthy young ApoE4 carriers: An MRI study. PLOS One. 2012;7(11)","DOI":"10.1371\/journal.pone.0048895"},{"key":"2024062101200632000_2024.04.18.590160v2.10","doi-asserted-by":"crossref","unstructured":"Reas ET , Triebswetter C , Banks SJ , McEvoy LK . Effects of APOE2 and APOE4 on brain microstructure in older adults: Modification by age, sex, and cognitive status. Alzheimer\u2019s Research & Therapy. 2024;16","DOI":"10.1186\/s13195-023-01380-w"},{"key":"2024062101200632000_2024.04.18.590160v2.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0811879106"},{"key":"2024062101200632000_2024.04.18.590160v2.12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroimage.2013.11.042","article-title":"Differential effects of the ApoE4 genotype on brain structure and function","volume":"89","year":"2014","journal-title":"NeuroImage"},{"key":"2024062101200632000_2024.04.18.590160v2.13","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3987-10.2010"},{"key":"2024062101200632000_2024.04.18.590160v2.14","doi-asserted-by":"crossref","unstructured":"Hong YJ , Kim C-M , Lee JH , Sepulcre J . Correlations between APOE4 allele and regional amyloid and tau burdens in cognitively normal older individuals. Scientific Reports. 2022;12","DOI":"10.1038\/s41598-022-18325-2"},{"key":"2024062101200632000_2024.04.18.590160v2.15","doi-asserted-by":"crossref","unstructured":"Emrani S , Arain HA , DeMarshall C , Nuriel T . APOE4 is associated with cognitive nad pathological heterogeneity in patients with Alzheimer\u2019s disease: A systematic review. Alzheimer\u2019s Research & Therapy. 2020;12(141)","DOI":"10.1186\/s13195-020-00712-4"},{"key":"2024062101200632000_2024.04.18.590160v2.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4668"},{"key":"2024062101200632000_2024.04.18.590160v2.17","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx155"},{"key":"2024062101200632000_2024.04.18.590160v2.18","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2994-18.2019"},{"key":"2024062101200632000_2024.04.18.590160v2.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.12.044"},{"key":"2024062101200632000_2024.04.18.590160v2.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0004-z"},{"key":"2024062101200632000_2024.04.18.590160v2.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0886-4"},{"key":"2024062101200632000_2024.04.18.590160v2.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2247-3"},{"key":"2024062101200632000_2024.04.18.590160v2.23","doi-asserted-by":"crossref","unstructured":"Konijnenberg E , Tijms BM , Gobom J , et al. APOE \u03b54 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy. 2020;12","DOI":"10.1186\/s13195-020-00628-z"},{"key":"2024062101200632000_2024.04.18.590160v2.24","doi-asserted-by":"crossref","unstructured":"Tao Q , Zhang C , Mercier G , et al. Identification of an APOE \u03b54-specific blood-based molecular pathway for Alzhiemer\u2019s disease risk. Alzheimer\u2019s & Dementia. 2023;15(4)","DOI":"10.1002\/dad2.12490"},{"issue":"1","key":"2024062101200632000_2024.04.18.590160v2.25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/jamaneurol.2016.4406","article-title":"Association of cerebrospinal fluid ferritin level with preclinical cognitive decline in APOE-\u03b54 carriers","volume":"74","year":"2017","journal-title":"JAMA Neurology"},{"issue":"2","key":"2024062101200632000_2024.04.18.590160v2.26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3233\/JAD-200747","article-title":"APOE4 copy number-dependent proteomic changes in the cerebrospinal fluid","volume":"79","year":"2021","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"3","key":"2024062101200632000_2024.04.18.590160v2.27","first-page":"201","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): Clinical characterization","volume":"74","year":"2009","journal-title":"Neurology"},{"key":"2024062101200632000_2024.04.18.590160v2.28","unstructured":"Wang L , Timsina J , Western D , Sung YJ , Cruchaga C. Data from: ADNI CSF SomaScan 7k Proteomic Data. 2023."},{"key":"2024062101200632000_2024.04.18.590160v2.29","unstructured":"Shaw LM , Korecka M , Wan Y , Sciulli A , Lee EB , Brylska M. An overview of the Roche Elecsys ADNI CSF batch analyses run in ADNI3. 2011. Alzheimer\u2019s Disease Neuroimaging Initiative Database."},{"key":"2024062101200632000_2024.04.18.590160v2.30","first-page":"388","article-title":"Artificial intelligence-driven meta-analysis of brain gene expression identifies novel gene candidates and a role for mitochondria in Alzheimer\u2019s disease","volume":"21","year":"2022","journal-title":"Computational and Structural Biotechnology Journal"},{"key":"2024062101200632000_2024.04.18.590160v2.31","doi-asserted-by":"crossref","unstructured":"Shvetcov A , Thomson S , Spathos J , et al. Blood-based transcriptomic biomarkers are predictive of neurodegeneration rather than Alzheimer\u2019s disease International Journal of Molecular Sciences. 2023;24(19)","DOI":"10.3390\/ijms241915011"},{"key":"2024062101200632000_2024.04.18.590160v2.32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz240"},{"key":"2024062101200632000_2024.04.18.590160v2.33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1147"},{"key":"2024062101200632000_2024.04.18.590160v2.34","unstructured":"Karlsson M , Zhang C , Mear L , et al. A single-cell type transcriptomics map of human tissues. Science Advances. 2021;7(31)"},{"key":"2024062101200632000_2024.04.18.590160v2.35","unstructured":"Sjostedt E , Zhong W , Fagerberg L , et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science. 2020;367"},{"key":"2024062101200632000_2024.04.18.590160v2.36","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-014-9263-8"},{"issue":"12","key":"2024062101200632000_2024.04.18.590160v2.37","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaneurol.2023.4038","article-title":"ApoE4 and connectivity-mediated spreading of tau pathology at lower amyloid levels","volume":"80","year":"2023","journal-title":"JAMA Neurology"},{"key":"2024062101200632000_2024.04.18.590160v2.38","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-009-9118-x"},{"key":"2024062101200632000_2024.04.18.590160v2.39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318245d295"},{"key":"2024062101200632000_2024.04.18.590160v2.40","doi-asserted-by":"publisher","DOI":"10.1159\/000051246"},{"key":"2024062101200632000_2024.04.18.590160v2.41","first-page":"637","article-title":"Tau pathology in cognitively normal older adults. Alzheimer\u2019s & Dementia: Diagnosis, Assessment","volume":"11","year":"2019","journal-title":"& Disease Monitoring"},{"issue":"2","key":"2024062101200632000_2024.04.18.590160v2.42","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-191250","article-title":"Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer\u2019s disease carrying apolipoprotein E4 genotype","volume":"76","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"2024062101200632000_2024.04.18.590160v2.43","first-page":"201","volume":"40","year":"2020","journal-title":"Increased apolipoprotein E and decreased TNF-\u03b1 in the cerebrospinal fluid of nondemented Neuropsychopharmacology Reports"},{"key":"2024062101200632000_2024.04.18.590160v2.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.01.032"},{"issue":"9","key":"2024062101200632000_2024.04.18.590160v2.45","first-page":"e195","article-title":"Apolipoprotein E4 expression causes gain of toxic function in isogenic human induced pluripotent stem cell-derived endothelial cells. Arteriosclerosis","volume":"39","year":"2019","journal-title":"Thrombosis, and Vascular Biology"},{"key":"2024062101200632000_2024.04.18.590160v2.46","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","article-title":"Peripheral apoE4 enhances Alzhiemer\u2019s pathology and impairs cognition by compromising cerebrovascular function","volume":"25","year":"2022","journal-title":"Nature Neuroscience"},{"key":"2024062101200632000_2024.04.18.590160v2.47","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21843"},{"issue":"4","key":"2024062101200632000_2024.04.18.590160v2.48","first-page":"643","article-title":"Apolipoprotein E: Risk factor for Alzheimer disease","volume":"54","year":"1994","journal-title":"American Journal of Human Genetics"},{"issue":"12","key":"2024062101200632000_2024.04.18.590160v2.49","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","article-title":"APOE genotype and Alzheimer disease risk across age, sex, and population ancestry","volume":"80","year":"2023","journal-title":"JAMA Neurology"},{"key":"2024062101200632000_2024.04.18.590160v2.50","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygozity represents a distinct genetic form of Alzheimer\u2019s disease","volume":"30","year":"2024","journal-title":"Nature Medicine"},{"issue":"4","key":"2024062101200632000_2024.04.18.590160v2.51","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3233\/JAD-181234","article-title":"Sex difference in the association of APOE4 with memory decline in mild cognitive impairment","volume":"69","author":"Alzheimer\u2019s Disease Neuroimaging Initiative.","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease."},{"key":"2024062101200632000_2024.04.18.590160v2.52","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24135"},{"key":"2024062101200632000_2024.04.18.590160v2.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.03.012"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.04.18.590160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:19:18Z","timestamp":1768457958000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.04.18.590160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":53,"URL":"https:\/\/doi.org\/10.1101\/2024.04.18.590160","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1111\/acel.14439","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,4,22]]},"subtype":"preprint"}}